REQUEST A DEMO
Total
USD $0.00
Search more companies

Sam-A Pharm. Co.,Ltd (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Sam-A Pharm. Co.,Ltd Profile Updated: July 23, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Sam-A Pharm. Co.,Ltd. is engaged in manufacturing of pharmaceutical products. The company offer its products in 3 categories: ETC medicines including respiratory, antibiotics, antivirals, antifungals, dermatology products, medicines for pain and inflammation, as well as medicines for gastrointestinals, cardiovascular, metabolism, urological and anti-histamines; OTC medicines such as "Selberin Q", "Lactobebe-S" powder, "DIOTIN-F" tablet, and "Tantum Verde Nebulizer"; and NOMA vitamins including "NOMA-F" chewables, "NOMA Chewable" tablet and "NAMA GOLD" chewable tablets. Sam-A Pharm. Co.,Ltd. is based in Seoul, South Korea. The company was incorporated in 1973 formerly known as Bo-Gun Pharmaceutical Co., Ltd.

Headquarters
1676 Donghwa-Ri Munmak-Eup, Wonju-Si
Wonju; Gangwon; Postal Code: 220-801

Contact Details: Purchase the Sam-A Pharm. Co.,Ltd report to view the information.

Website: http://www.samapharm.co.kr

Basic Information
Total Employees:
Purchase the Sam-A Pharm. Co.,Ltd report to view the information.
Outstanding Shares:
Purchase the Sam-A Pharm. Co.,Ltd report to view the information.
Registered Capital:
Purchase the Sam-A Pharm. Co.,Ltd report to view the information.
Financial Auditors:
Purchase the Sam-A Pharm. Co.,Ltd report to view the information.
Incorporation Date:
October 04, 1973
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
44.36%
Purchase this report to view the information.
13.13%
Purchase this report to view the information.
4.8%
Purchase this report to view the information.
3.29%
Subsidiaries
삼아제약(주)
Company Performance
Financial values in the chart are available after Sam-A Pharm. Co.,Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
24.73%
Total operating revenue
25.17%
Operating profit (EBIT)
44.54%
EBITDA
36.89%
Net Profit (Loss) for the Period
104.79%
Total assets
12.99%
Total equity
10.21%
Operating Profit Margin (ROS)
3.42%
Net Profit Margin
8.95%
Return on Equity (ROE)
3.88%
Debt to Equity Ratio
1.58%
Quick Ratio
-0.55%
Cash Ratio
0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?